{"id":129154,"date":"2023-01-24T15:19:53","date_gmt":"2023-01-24T15:19:53","guid":{"rendered":"https:\/\/ccs.ca\/?page_id=129154"},"modified":"2024-06-10T08:40:18","modified_gmt":"2024-06-10T12:40:18","slug":"mycovacc","status":"publish","type":"page","link":"https:\/\/ccs.ca\/mycovacc\/","title":{"rendered":"MYCOVACC"},"content":{"rendered":"\n<h5 class=\"wp-block-heading\">The CCS<em>&nbsp;<\/em>National Active Surveillance Study of Myocarditis and\/or Pericarditis following mRNA COVID-19 Vaccination (MYCOVACC)&nbsp;<\/h5>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"506\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg\" alt=\"\" class=\"wp-image-129168\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-300x148.jpg 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-768x380.jpg 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1536x760.jpg 1536w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-390x193.jpg 390w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2.jpg 2016w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Members of the MYCOVACC Study Team, from left to right: Dr. Peter Liu, Dr. Sean Virani, Dr. Michael McDonald, Meredith Wright, Dr. Tahir Kafil, Susanna Ogunnaike-Cooke, Carolyn Pullen, Dr. Nat Hawkins at the 2022 Canadian Cardiovascular Congress in Ottawa. <\/figcaption><\/figure><\/div>\n\n\n<h3 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"press-releases\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Press Releases<\/mark><\/h3>\n\n\n\n<ul>\n<li><a href=\"https:\/\/ccs.ca\/news\/canadian-cardiovascular-society-awarded-1-4m-to-continue-important-national-study-of-covid-19-and-mrna-vaccines\/\">June 7, 2024<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/news\/canadian-cardiovascular-society-receives-2m-to-expand-study-of-covid-19-mrna-vaccines\/\">June 21, 2023<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/news\/canadian-cardiovascular-society-receives-1-6-million-to-study-myocarditis-and-or-pericarditis-after-mrna-covid-19-vaccination\/\">October 27, 2022<\/a><\/li>\n<\/ul>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"study\">Join the MYCOVACC study<\/h5>\n\n\n\n<p>The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from across the country to contribute to this multi-centre study. Study participants will be assessed at three months and 12 months after diagnosis and then annually for up to three years by a participating specialist. They will also be invited to complete quality of life, mental health, physical activity, and health&nbsp;outcomes questionnaires. <\/p>\n\n\n\n<p><strong>Contact the MYCOVACC study team<\/strong>: <a href=\"mailto:mycovacc@ccs.ca\">mycovacc@ccs.ca<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"newsletters\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Newsletters<\/mark><\/h3>\n\n\n\n<ul>\n<li><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-June-2024-Newsletter-EN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">June 2024<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-January-2024-Newsletter-EN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">January 2024<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/07\/MYCOVACC-June-Newsletter-EN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">June 2023<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/03\/MYCOVACC-March-Newsletter-EN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">March 2023<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-January-Newsletter-EN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">January 2023<\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"learn-more\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Learn More<\/mark><\/h3>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>Read (NEW): <\/strong><br>McDonald, M.A., Kafil, T.S, Khoury, M., Luk, A.C., Wright, M.K, &amp; Hawkins, N. M. (2024). Myocarditis and pericarditis following mRNA COVID-19 vaccination: 2024 status and management update. <em>Canadian Journal of Cardiology<\/em>.&nbsp; <a href=\"https:\/\/doi.org\/10.1016\/j.cjca.2024.03.016\">https:\/\/doi.org\/10.1016\/j.cjca.2024.03.016<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-style-default\"><a href=\"https:\/\/doi.org\/10.1016\/j.cjca.2024.03.016\" target=\"_blank\" rel=\"noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-1024x576.png\" alt=\"\" class=\"wp-image-135463\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-1024x576.png 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-300x169.png 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-768x432.png 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-1536x864.png 1536w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC-356x200.png 356w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/MYCOVACC.png 1600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-2 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>Watch (NEW):<\/strong><br><a href=\"https:\/\/attendee.gotowebinar.com\/recording\/9003881367006486272\" target=\"_blank\" rel=\"noreferrer noopener\">Myocarditis and Pericarditis after mRNA COVID-19 Vaccination: Status and Management Update (2024)<\/a><\/p>\n\n\n\n<p>This CCS continuing professional development webinar provides an update on post-vaccine myocarditis and pericarditis from public health, cardiology, and family medicine perspectives.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-1024x576.png\" alt=\"\" class=\"wp-image-135934\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-1024x576.png 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-300x169.png 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-768x432.png 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-1536x864.png 1536w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN-356x200.png 356w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/06\/MYCOVACC-Webinar-Recording-for-Social-EN.png 1600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-3 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>Watch:<\/strong><br><a href=\"https:\/\/attendee.gotowebinar.com\/recording\/8206124105593049264\" target=\"_blank\" rel=\"noreferrer noopener\">Vaccine-Associated Myocarditis: Insights from the CCS MYCOVACC Surveillance Study (2023)<\/a><\/p>\n\n\n\n<p>This Vascular 2023 session updates the Canadian cardiovascular community on MYCOVACC.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-style-default\"><a href=\"https:\/\/attendee.gotowebinar.com\/recording\/8206124105593049264\" target=\"_blank\" rel=\"noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-1024x576.png\" alt=\"\" class=\"wp-image-133558\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-1024x576.png 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-300x169.png 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-768x432.png 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-1536x864.png 1536w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular-356x200.png 356w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/01\/MYCOVACC-Vascular.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"patient-and-healthcare-provider-resources-new\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Patient and Healthcare Provider Resources (NEW)<\/mark><\/h3>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-4 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p><strong>Information for Patients:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-medium is-resized is-style-default\"><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"231\" height=\"300\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-231x300.jpg\" alt=\"\" class=\"wp-image-135477\" style=\"width:200px\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-231x300.jpg 231w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-789x1024.jpg 789w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-768x997.jpg 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-1183x1536.jpg 1183w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-1577x2048.jpg 1577w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-154x200.jpg 154w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Patient_Info_ENG_FNL-scaled.jpg 1972w\" sizes=\"(max-width: 231px) 100vw, 231px\" \/><\/a><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p><strong>Management Algorithm for Health Care Providers:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-medium is-resized is-style-default\"><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"231\" height=\"300\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-231x300.jpg\" alt=\"\" class=\"wp-image-135479\" style=\"width:200px\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-231x300.jpg 231w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-789x1024.jpg 789w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-768x997.jpg 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-1183x1536.jpg 1183w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-1577x2048.jpg 1577w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-154x200.jpg 154w, https:\/\/ccs.ca\/wp-content\/uploads\/2024\/04\/CCS-MYCOVACC_Provider_Info_ENG_FNL-scaled.jpg 1972w\" sizes=\"(max-width: 231px) 100vw, 231px\" \/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p>The updated post-vaccine myocarditis and pericarditis resources were developed in collaboration with the Centre for Evidence-Based Implementation, McMaster University. They are informed by <a href=\"https:\/\/doi.org\/10.1016\/j.cjca.2024.03.016\" target=\"_blank\" rel=\"noreferrer noopener\">Myocarditis and Pericarditis following mRNA COVID-19 Vaccination: 2024 Status and Management Update<\/a> in the Canadian Journal of Cardiology.&nbsp; The resources are available in English and French.<a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"governance\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Governance<\/mark><\/h3>\n\n\n\n<p>The MYCOVACC governance structure aims to facilitate the participation and collaboration of CCS members, CCS Affiliate societies, investigators, and patients in study activities.<\/p>\n\n\n<div class=\"wp-block-image is-resized is-style-default\">\n<figure class=\"aligncenter size-large\"><a href=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1.png\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-1024x1024.png\" alt=\"\" class=\"wp-image-129379\" style=\"width:550px\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-1024x1024.png 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-300x300.png 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-150x150.png 150w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-768x768.png 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-200x200.png 200w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1-100x100.png 100w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC-Governance-Structure-1.png 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure><\/div>\n\n\n<h5 class=\"wp-block-heading\" id=\"steering\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Steering Committee<\/mark><\/h5>\n\n\n\n<p>The MYCOVACC Steering Committee is chaired by Dr. Nathaniel Hawkins. It includes CCS members as well as representatives from key partner networks and the Public Health Agency of Canada. <\/p>\n\n\n\n<p><a href=\"https:\/\/ccs.ca\/mycovacc-steering-committee\/\">Read member biographies<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-medium\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"57\" src=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR-300x57.png\" alt=\"\" class=\"wp-image-129176\" srcset=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR-300x57.png 300w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR-1024x194.png 1024w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR-768x145.png 768w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR-390x74.png 390w, https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/FIP-PHAC-financialContribu_EnBR.png 1495w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/figure><\/div>\n\n\n<p>The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The CCS&nbsp;National Active Surveillance Study of Myocarditis and\/or Pericarditis following mRNA COVID-19 Vaccination (MYCOVACC)&nbsp; Press Releases Join the MYCOVACC study The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from across the country to contribute to this multi-centre study. Study participants will be assessed at three months and 12 months after diagnosis [&hellip;]<\/p>\n","protected":false},"author":7813,"featured_media":0,"parent":0,"menu_order":242,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"wf_page_folders":[388],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MYCOVACC - Canadian Cardiovascular Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccs.ca\/mycovacc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MYCOVACC - Canadian Cardiovascular Society\" \/>\n<meta property=\"og:description\" content=\"The CCS&nbsp;National Active Surveillance Study of Myocarditis and\/or Pericarditis following mRNA COVID-19 Vaccination (MYCOVACC)&nbsp; Press Releases Join the MYCOVACC study The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from across the country to contribute to this multi-centre study. Study participants will be assessed at three months and 12 months after diagnosis [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccs.ca\/mycovacc\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Cardiovascular Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-10T12:40:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@SCC_CCS\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccs.ca\/mycovacc\/\",\"url\":\"https:\/\/ccs.ca\/mycovacc\/\",\"name\":\"MYCOVACC - Canadian Cardiovascular Society\",\"isPartOf\":{\"@id\":\"https:\/\/ccs.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ccs.ca\/mycovacc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ccs.ca\/mycovacc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg\",\"datePublished\":\"2023-01-24T15:19:53+00:00\",\"dateModified\":\"2024-06-10T12:40:18+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccs.ca\/mycovacc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ccs.ca\/mycovacc\/#primaryimage\",\"url\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2.jpg\",\"contentUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2.jpg\",\"width\":2016,\"height\":997},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccs.ca\/#website\",\"url\":\"https:\/\/ccs.ca\/\",\"name\":\"Canadian Cardiovascular Society\",\"description\":\"Strong heart teams in a heart-healthy Canada.\",\"publisher\":{\"@id\":\"https:\/\/ccs.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccs.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccs.ca\/#organization\",\"name\":\"Canadian Cardiovascular Society\",\"url\":\"https:\/\/ccs.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"contentUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"width\":699,\"height\":250,\"caption\":\"Canadian Cardiovascular Society\"},\"image\":{\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\",\"https:\/\/x.com\/SCC_CCS\",\"https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MYCOVACC - Canadian Cardiovascular Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccs.ca\/mycovacc\/","og_locale":"en_US","og_type":"article","og_title":"MYCOVACC - Canadian Cardiovascular Society","og_description":"The CCS&nbsp;National Active Surveillance Study of Myocarditis and\/or Pericarditis following mRNA COVID-19 Vaccination (MYCOVACC)&nbsp; Press Releases Join the MYCOVACC study The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from across the country to contribute to this multi-centre study. Study participants will be assessed at three months and 12 months after diagnosis [&hellip;]","og_url":"https:\/\/ccs.ca\/mycovacc\/","og_site_name":"Canadian Cardiovascular Society","article_publisher":"https:\/\/www.facebook.com\/SCC.CCS.ca\/","article_modified_time":"2024-06-10T12:40:18+00:00","og_image":[{"url":"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg"}],"twitter_card":"summary_large_image","twitter_site":"@SCC_CCS","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccs.ca\/mycovacc\/","url":"https:\/\/ccs.ca\/mycovacc\/","name":"MYCOVACC - Canadian Cardiovascular Society","isPartOf":{"@id":"https:\/\/ccs.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ccs.ca\/mycovacc\/#primaryimage"},"image":{"@id":"https:\/\/ccs.ca\/mycovacc\/#primaryimage"},"thumbnailUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2-1024x506.jpg","datePublished":"2023-01-24T15:19:53+00:00","dateModified":"2024-06-10T12:40:18+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccs.ca\/mycovacc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ccs.ca\/mycovacc\/#primaryimage","url":"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2.jpg","contentUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2023\/01\/MYCOVACC2.jpg","width":2016,"height":997},{"@type":"WebSite","@id":"https:\/\/ccs.ca\/#website","url":"https:\/\/ccs.ca\/","name":"Canadian Cardiovascular Society","description":"Strong heart teams in a heart-healthy Canada.","publisher":{"@id":"https:\/\/ccs.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccs.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ccs.ca\/#organization","name":"Canadian Cardiovascular Society","url":"https:\/\/ccs.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/","url":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","contentUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","width":699,"height":250,"caption":"Canadian Cardiovascular Society"},"image":{"@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCC.CCS.ca\/","https:\/\/x.com\/SCC_CCS","https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society"]}]}},"_links":{"self":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/129154"}],"collection":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/users\/7813"}],"replies":[{"embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/comments?post=129154"}],"version-history":[{"count":58,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/129154\/revisions"}],"predecessor-version":[{"id":135952,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/129154\/revisions\/135952"}],"wp:attachment":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/media?parent=129154"}],"wp:term":[{"taxonomy":"wf_page_folders","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/wf_page_folders?post=129154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}